Importantly, in a variety of CKD models, the inhibition of the renin–angiotensin system reduced Ccl2-mediated inflammation and a pharmacological inhibition of Ccl2 reduced renal damage [91,92,93,94,95]. Here, CCL2 is linked to chronic kidney disease.